November - 14 - 2022ISSN 2644-2787$15www.pharmatechoutlook.comEDI T I O NQUALITY ASSURANCEMatt Southwick,Executive Director Clinical Systems and Analytical Reporting,Amgen [NASDAQ:AMGN]ANALYTICS AS A COMPETITIVE ADVANTAGE TAKES 3 THINGS­ACCESS, CLEANLINESS, AND ACTION
Page 2 >